Evidence map›Paper›PMID 26243397›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2016

The expression and function of Frizzled-7 in human renal cell carcinoma.

R Xu, S Zeng, W Xie, C Sun, Y L Chen, M J Chen, L Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. FrizzledHandbook of experimental pharmacology · 2021
    Article
  5. Wnt Signaling in Kidney Development and Disease.Progress in molecular biology and translational science · 2018
    Review
  6. Frizzled-7 is required forBiology open · 2017
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

R XuDepartment of Pharmacy, College of Pharmaceutical Science, Soochow University, Suzhou, 215123, China.
S ZengDepartment of Pharmacy, College of Pharmaceutical Science, Soochow University, Suzhou, 215123, China.
W XieDepartment of Immunology, School of Basic Medicine and Life Sciences, Medical College, Soochow University, Suzhou, China.
C SunThe Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Y L ChenDepartment of Pharmacy, College of Pharmaceutical Science, Soochow University, Suzhou, 215123, China.
M J ChenDepartment of Pharmacy, College of Pharmaceutical Science, Soochow University, Suzhou, 215123, China.
L ZhangDepartment of Pharmacy, College of Pharmaceutical Science, Soochow University, Suzhou, 215123, China. cpuzl@163.com.
Soochow University · CNSecond Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWnt/β-catenin has emerged as an important signal pathway in renal cell carcinoma (RCC) pathogenesis. Frizzled 7 (Fzd7) is a member of Frizzled (Fzd) receptor family which binds with Wnt ligands and transduces canonical and non-canonical pathways. However, the expression of Fzd7 in human RCC is poorly investigated.

methods53 RCC tissues and peri-tumor tissues were collected from the patients treated with radical nephrectomy. The expression of Fzd7 was investigated by immunohistochemical staining. Three RCC cells were transfected with Fzd7shRNA and GFPshRNA to investigate the function of Fzd7 in RCC cells.

resultsThe immunohistochemical analysis showed that Fzd7 protein expression level was significantly increased in RCC tissues when compared with peri-tumor tissues, which suggested that Fzd7 might be involved in the formation of tumors. However, the Fzd7 expression was not correlated with clinicopathological parameters. Three RCC cell lines: 786-O, Caki-1, and OS-RC-2 also expressed Fzd7. With Fzd7 expression being interfered by shRNA, the RCC cell proliferation was mildly decreased. Wnt3a could stimulate the RCC cells proliferation, but the stimulation was decreased when Fzd7 expression was interfered. Restoring the Fzd7 expression led to the proliferation stimulation effect of Wnt3a being restored.

conclusionsThis paper suggests that Fzd7 may act as one of the molecules that take part in the course of RCC formation. Fzd7 can be activated by Wnt3a to stimulate cell proliferation.

Indexed as

AdultAgedCarcinoma, Renal CellCell ProliferationFemaleFlow CytometryFrizzled ReceptorsHumansImmunohistochemistryKidney NeoplasmsMaleMiddle AgedPolymerase Chain ReactionRNA, Small InterferingTransfectionFrizzled ReceptorsFZD7 protein, humanRNA, Small InterferingCell proliferationFrizzled 7 (Fzd7)Renal cell carcinoma (RCC)Wnt3a

Identifiers

PMID26243397
OpenAlexW1117369035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.